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Background: Recent studies have indicated that low serum testosterone levels are associated with increased risk of
developing hepatic steatosis; however, the mechanisms mediating this phenomenon have not been fully
elucidated. To gain insight into the role of testosterone in modulating hepatic steatosis, we investigated the effects
of testosterone on the development of hepatic steatosis in pigs fed a high-fat and high-cholesterol (HFC) diet and
profiled hepatic gene expression by RNA-Seq in HFC-fed intact male pigs (IM), castrated male pigs (CM), and
castrated male pigs with testosterone replacement (CMT).
Results: Serum testosterone levels were significantly decreased in CM pigs, and testosterone replacement
attenuated castration-induced testosterone deficiency. CM pigs showed increased liver injury accompanied by
increased hepatocellular steatosis, inflammation, and elevated serum alanine aminotransferase levels compared with
IM pigs. Moreover, serum levels of total cholesterol, low-density lipoprotein cholesterol, and triglycerides were
markedly increased in CM pigs. Testosterone replacement decreased serum and hepatic lipid levels and improved
liver injury in CM pigs. Compared to IM and CMT pigs, CM pigs had lower serum levels of superoxide dismutase
but higher levels of malondialdehyde. Gene expression analysis revealed that upregulated genes in the livers of CM
pigs were mainly enriched for genes mediating immune and inflammatory responses, oxidative stress, and apoptosis.
Surprisingly, the downregulated genes mainly included those that regulate metabolism-related processes, including
fatty acid oxidation, steroid biosynthesis, cholesterol and bile acid metabolism, and glucose metabolism. KEGG analysis
showed that metabolic pathways, fatty acid degradation, pyruvate metabolism, the tricarboxylic acid cycle, and the
nuclear factor-kappaB signaling pathway were the major pathways altered in CM pigs.
Conclusions: This study demonstrated that testosterone deficiency aggravated hypercholesterolemia and hepatic
steatosis in pigs fed an HFC diet and that these effects could be reversed by testosterone replacement therapy.
Impaired metabolic processes, enhanced immune and inflammatory responses, oxidative stress, and apoptosis may
contribute to the increased hepatic steatosis induced by testosterone deficiency and an HFC diet. These results
deepened our understanding of the molecular mechanisms of testosterone deficiency-induced hepatic steatosis and
provided a foundation for future investigations.
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Serum testosterone levels decline gradually and progres-
sively with aging in men. Low levels of testosterone are
associated with metabolic disorders, including obesity,
dyslipidemia, hypertension, and insulin resistance [1], all
of which contribute to the development of nonalcoholic
fatty liver disease (NAFLD) [2]. Recent studies have
shown that men with low serum testosterone levels have
a higher risk of developing hepatic steatosis [3-5]. More-
over, animal studies have demonstrated that the incidence
of hepatic steatosis is increased in testosterone-deficient
male mice [6,7]. These findings indicate the important
role of testosterone in the pathophysiology of NAFLD.
However, nutritional parameters, especially a high-
cholesterol diet, have been also associated with the
development of NAFLD [2,8]. Hypercholesterolemia in-
duced by dietary cholesterol has recently been indicated
as a major risk factor for hepatic steatosis [9,10]. In the
absence of testosterone, mice develop hypercholesterol-
emia when fed a diet with no added cholesterol [11].
Hypercholesterolemia and elevated serum cholesterol
levels are also observed in hypogonadal men [12,13].
Therefore, these previous findings suggest that testos-
terone deficiency and testosterone deficiency-induced
hypercholesterolemia may aggravate the severity of
NAFLD induced by a high-cholesterol diet. However,
the mechanisms underlying the effects of testosterone
deficiency on the promotion of diet-induced hepatic
steatosis remain unclear.
Previous studies have used rodent models to investi-
gate the influence of testosterone on the development
of hepatic steatosis. For example, hepatic androgen
receptor-knockout male mice receiving a high-fat diet
develop insulin resistance and hepatic steatosis [14].
Moreover, dihydrotestosterone suppresses diet-induced
hepatic steatosis in castrated male rats [15], and hepatic
lipid deposition is elevated in testicular feminized mice
(Tfm) compared with intact wild-type littermate controls
[7]. Although rodents are commonly used to study hep-
atic steatosis and have provided valuable insights into
the pathogenesis of this disease, the relevance of these
models to human disease is limited [16]. As an alterna-
tive to rodent models, large animal models, such as pigs,
may be more relevant to the study of NAFLD because
these models more closely mimic human physiology and
anatomy [16-18]. Importantly, castration-induced sex
hormone deficiency in male pigs results in obesity, ele-
vated serum triglycerides (TGs), and increased cholesterol
levels [19,20], some of the typical causes of NAFLD,
suggesting that pigs are suitable models for studying the
effects of sex hormones on NAFLD development.
Despite the importance of testosterone in the regulation
of hepatic steatosis, the genomic mechanisms through
which testosterone deficiency aggravates diet-inducedhepatic steatosis are still unclear. Transcriptome pro-
filing is an effective and widely used tool to identify
critical genes and pathways involved in pathological
processes. Sequencing-based and hybridization-based
approaches represent the two major approaches used
in transcriptomics studies [21]. High-throughput RNA
sequencing (RNA-Seq) has recently become an attract-
ive method of choice in the study of transcriptomes,
providing several advantages over microarrays.
In this study, we sought to gain insights into the roles
of testosterone in modulating hepatic steatosis using a
porcine model of testosterone deficiency and diet-
induced hepatic steatosis. Additionally, we examined the
contribution of liver genes to the development of hepatic
steatosis induced by testosterone deficiency and a high-
cholesterol diet using RNA-Seq. To the best of our
knowledge, this is the first description of differences in
whole-transcriptome patterns occurring in the liver fol-
lowing castration in pigs fed a high-cholesterol diet.
Results
Body weights and serum testosterone levels
Pigs were separated into three groups: intact male pigs
fed a high-fat and high-cholesterol (HFC) diet (IM); cas-
trated male pigs fed an HFC diet (CM); and castrated
male pigs fed an HFC diet and given testosterone re-
placement therapy (CMT). The body weights of pigs in
each group were calculated and found to be linearly ele-
vated over time. Initial body weights were similar in pigs
from the IM, CM, and CMT groups (12.76 ± 0.45, 12.14
± 0.35, and 12.35 ± 0.89 kg, respectively). Castrated pigs
fed an HFC diet gained less weight than did pigs in the
other groups. With testosterone replacement, the body
weights of CMT pigs increased and were similar to the
body weights of pigs in the IM group (Figure 1A).
Serum testosterone concentrations were not significantly
different between groups before the study began (0 weeks).
As expected, castration caused a significant decrease in
serum testosterone levels. The concentration of serum
testosterone at 12 weeks was significantly lower in CM
pigs than in IM pigs (0.24 ± 0.05 vs. 3.52 ± 0.25 ng/mL,
respectively). Testosterone treatment increased serum
testosterone levels to 4.43 ± 0.31 ng/mL (Figure 1B).
Liver weight, body fat content, and serum biochemical
parameters
Liver weight, body fat content, and serum biochemical
parameters after 12 weeks of HFC feeding are presented
in Table 1. The liver weights in CM pigs were higher
than those observed in IM pigs, but lower than those in
CMT pigs (P > 0.05). Liver weight indexes in CM pigs
were higher than those in IM and CMT pigs, but these
differences were not significant (P > 0.05). CM pigs had
higher body fat percentages than IM (P < 0.01) and CMT
Figure 1 Effects of castration and testosterone treatment on body weights and serum testosterone concentrations. (A) Body weights.
(B) Serum testosterone concentrations. IM: intact male pigs fed an HFC diet; CM: castrated male pigs fed an HFC diet; CMT: castrated male pigs
fed an HFC diet and given testosterone replacement therapy. Data are expressed as means ± SEMs, n = 6 per group. **P < 0.01.
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levels were significantly increased in CM pigs compared
with IM +HFC pigs (P < 0.05) and significantly reduced
in CMT pigs by testosterone replacement (P > 0.05). As-
partate aminotransferase (AST) levels were highest in
CM pigs, but the differences were not significant among
groups (P > 0.05). Compared with IM and CMT pigs,
CM pigs showed obviously lower serum levels of super-
oxide dismutase (SOD, P < 0.05) but higher levels of
malondialdehyde (MDA, P < 0.01). Serum free fatty acid
(FFA) levels tended to be higher in CM pigs than in IM
and CMT pigs. Fasting serum glucose and insulin levels
and homeostatic model assessment of insulin resistance
(HOMA-IR) were not significantly different betweenTable 1 Liver weight, body fat content and serum
biochemical parameters in miniature pigs fed a high-fat
and high-cholesterol diet
IM CM CMT
Body weight (kg) 25.15 ± 0.86 23.69 ± 0.64 26.21 ± 1.20
Liver weight (g) 483.82 ± 47.04 524.72 ± 69.88 558.38 ± 27.95
Liver weight index (%) 19.18 ± 1.74 22.01 ± 2.47 21.30 ± 0.39
Body fat (%) 0.15 ± 0.00** 0.24 ± 0.02 0.19 ± 0.01#
Serum
ALT (IU/L) 37.17 ± 2.20* 46.88 ± 0.86 42.45 ± 3.68
AST (IU/L) 42.37 ± 4.95 44.70 ± 6.86 41.45 ± 2.60
SOD (U/mL) 88.61 ± 7.09* 52.07 ± 9.58 100.69 ± 11.79##
GSH-PX (μmol/L) 810.07 ± 65.53 723.44 ± 61.82 900.43 ± 58.22
MDA(nmol/L) 3.30 ± 0.32** 5.89 ± 0.68 2.81 ± 0.19##
FFA (mmol/L) 0.70 ± 0.13 0.98 ± 0.14 0.65 ± 0.10
Glucose (mmol/L) 5.09 ± 0.13 4.94 ± 0.14 5.15 ± 0.15
Insulin (mIU/L) 27.40 ± 0.66 28.60 ± 0.76 21.1 ± 0.47##
HOMA-IR 6.17 ± 0.10 6.29 ± 0.33 4.81 ± 0.35##
*P < 0.05 and **P < 0.01, IM vs. CM; #P < 0.05 and ##P < 0.01, CMT vs. CM.CM and IM pigs (P > 0.05). However, testosterone re-
placement significant reduced serum insulin levels and
HOMA-IR in CM pigs (P < 0.01).Serum lipids
To analyze the effects of castration and testosterone
treatment on lipid metabolism in HFC-fed pigs, serum
lipids were measured at 0, 2, 4, 6, 8, 10, and 12 weeks
postcastration. Serum total cholesterol (TC), high-density
lipoprotein cholesterol (HDL-C), low-density lipoprotein
cholesterol (LDL-C), and TGs were significantly increased
in miniature pigs fed an HFC diet (Figure 2). CM pigs
had higher TC levels than did IM and CMT pigs from
the fourth week after HFC supplementation (P < 0.05;
Figure 2A). There were no significant differences in
serum TC levels between IM and CMT pigs (P > 0.05).
Serum LDL-C followed a pattern similar to that of TC
in all groups of pigs (Figure 2C). However, testosterone
deficiency caused by castration had no significant influ-
ence on serum HDL-C levels in HFC-fed pigs (Figure 2B).
Serum TG levels in CM pigs were higher than those in IM
pigs at weeks 10 and 12 (P < 0.05) and those in CMT pigs
beginning at week 4 (P < 0.05; Figure 2D).Liver histopathology and hepatic lipids
Liver histology results showed that testosterone defi-
ciency induced by castration significantly increased hep-
atic fat accumulation in pigs fed an HFC diet (Figure 3).
CM pigs developed massive micro- or macrovesicular
steatosis, while the hepatocytes of IM pigs showed only
mild microvesicular steatosis (Figure 3A). Moreover, cas-
tration significantly aggravated hepatic inflammation in
pigs fed an HFC diet (Figure 3A). Testosterone treat-
ment clearly improved hepatic steatosis and reduced
hepatic necroinflammation in CM pigs (Figure 3A). Oil
Figure 2 Effects of castration and testosterone treatment on serum lipid levels. (A) Serum total cholesterol (TC) levels. (B) Serum low-density
lipoprotein cholesterol (LDL-C) levels. (C) Serum high-density lipoprotein cholesterol (HDL-C) levels. (D) Serum triglyceride (TG) levels. IM: intact male
pigs fed an HFC diet; CM: castrated male pigs fed an HFC diet; CMT: castrated male pigs fed an HFC diet and given testosterone replacement therapy.
Data are expressed as means ± SEMs, n = 6 per group. *P < 0.05 and **P < 0.01, IM vs. CM; #P < 0.05 and ##P < 0.01, CMT vs. CM.
Figure 3 Effects of testosterone on liver histology and hepatic lipids. (A) Liver sections stained with hematoxylin and eosin. Micro- and
macrovesicular steatosis are indicated by arrow heads, and inflammation is indicated by arrows. (B) Oil red O staining of fat in hepatocytes. Increased
lipid deposition is indicated by arrows. (C) Hepatic triglyceride (TG) content in IM, CM, and CMT pigs. (D) Hepatic cholesterol (TC) content in IM,
CM, and CMT pigs. IM: intact male pigs fed an HFC diet; CM: castrated male pigs fed an HFC diet; CMT: castrated male pigs fed an HFC diet and
given testosterone replacement therapy. Data are expressed as means ± SEMs, n = 6 per group. *P < 0.05; **P < 0.01.
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lipid deposition in the livers of CM pigs (Figure 3B).
Consistent with the observed increase in lipid depos-
ition, we also detected marked increases in TG contents
in the livers of CM pigs (Figure 3C). Moreover, testoster-
one treatment reduced hepatic TG contents in CM pigs
(Figure 3C). Likewise, hepatic cholesterol contents in
CM pigs were also significantly higher than those in IM
and CMT pigs (P < 0.05; Figure 3D).
Gene expression analysis by RNA-Seq
To obtain a global view of the hepatic transcriptome re-
sponses to testosterone deficiency and testosterone treat-
ment in pigs fed an HFC diet, we performed comparative
RNA-Seq analyses of the liver transcriptomes. cDNA li-
braries were constructed using total RNA isolated from
the livers of IM, CM, and CMT pigs. Using an Illumina
HiSeq 2000 sequencer, we obtained approximately 40.58,
45.39, and 32.33 million high quality clean reads from IM,
CM, and CMT pigs, respectively. For each sample, ~87%
of reads could be mapped to the pig reference genome; of
these mapped reads, ~79% aligned with unique genes un-
ambiguously (Table 2).
In total, 18093, 18418, and 17740 expressed genes
were detected in the livers of IM, CM, and CMT pigs,
respectively. Of these genes, a total of 16981 genes were
expressed in all three groups; 584, 315, and 191 genes
were identified commonly between each pair of groups
(CM versus IM, CMT versus CM, and CMT versus IM,
respectively), while 337, 538, and 253 genes were discov-
ered exclusively for IM, CM, and CMT, respectively
(Additional file 1; Figure 4A). To identify differentially
expressed genes (DEGs) in the livers of IM, CM, and
CMT pigs, gene expression data from each group were
compared using DEGSeq software [22]. Significance
scores were corrected for multiple testing using the
Benjamini-Hochberg correction [23]. We used the fol-
lowing criteria to identify DEGs: (1) gene expression
level greater than or equal to 1 fragment per kilobases of
exon per million fragments mapped (FPKM) in all sam-
ples; (2) change in expression level greater than or equalTable 2 Summary of the sequencing reads alignment to
the reference genome
Statistics term IM CM CMT
All reads 40578646 45391430 32329976
Unmapped reads 4949040 5702066 4154466
Mapped reads 35629606 39689364 28175510
Mapping rate 0.878 0.874 0.871
Unique mapping 32288705 36243263 25183689
Unique mapping rate 0.796 0.798 0.779
Repeat mapping 3340701 3445877 2991640to 1.5 fold; and (3) a false discovery rate (FDR) of less
than 0.05 [24]. Thus, a total of 1635 (826 upregulated
and 809 downregulated), 1847 (915 upregulated and
934 downregulated), and 671 (313 upregulated and 358
downregulated) DEGs were detected in the livers of
pigs for CM versus IM, CMT versus CM, and CMT
versus IM groups, respectively (Figure 4B). In total,
2595 different genes were differentially expressed be-
tween any two groups (Figure 4C; DEG list provided in
Additional file 2).
Gene Ontology (GO) enrichment analysis of DEGs
To gain further insights into the biological functions of
DEGs, we performed GO analyses by querying each
DEG identified in the livers of IM, CM, and CMT pigs
against the GO database. GO analysis of significantly up-
regulated DEGs between CM and IM pigs revealed genes
that were mainly enriched in immune-related processes,
such as the type I interferon signaling pathway, the
cytokine-mediated signaling pathway, immune responses,
innate immune responses, antigen processing and presen-
tation, and apoptosis (Additional file 3). Downregulated
DEGs were mainly involved in metabolism-related pro-
cesses, such as lipid metabolism, fatty acid metabolism,
fatty acid beta-oxidation, bile acid metabolic processes,
steroid metabolic processes, ketone body biosynthetic
processes, cholesterol metabolic processes, and the tri-
carboxylic acid and gluconeogenesis pathways (Additional
file 3). Upregulated DEGs between CMT and CM pigs
revealed genes that were mainly involved in metabolism-
related processes, such as lipid metabolism, fatty acid me-
tabolism, fatty acid beta-oxidation, steroid metabolism,
bile acid metabolism, cholesterol metabolism, ketone body
biosynthesis, and the tricarboxylic acid and gluconeo-
genesis cycles, while downregulated DEGs were mainly
enriched in immune-related processes, such as the type I
interferon signaling pathway, the cytokine-mediated sig-
naling pathway, innate immune responses, immune re-
sponses, apoptosis, antigen processing and presentation,
inflammatory responses, and responses to oxidative stress
(Additional file 4).
The enriched GO analyses of all significant DEGs be-
tween any two groups were also investigated and were
found to be mainly involved in small molecule metabol-
ism, metabolic processes, lipid metabolism, fatty acid
metabolism, steroid metabolism, cholesterol metabolism,
fatty acid beta-oxidation, immune responses, inflamma-
tory responses, apoptosis, and responses to oxidative
stress (Figure 5A, Additional file 5).
Pathway analysis of DEGs
Pathway analysis using the KEGG database was per-
formed to determine significant pathways involving the
DEGs identified in this study. Our results showed that
Figure 4 RNA-Seq analyses of differentially expressed genes (DEGs) in livers of IM, CM, and CMT pigs. (A) The numbers of upregulated
and downregulated DEGs between groups. (B) Venn diagram showing the overlap of DEGs between groups. (C) Heat map for hierarchical cluster
analysis of DEGs between samples. Red: upregulated genes; yellow: downregulated genes. IM: intact male pigs fed an HFC diet; CM: castrated
male pigs fed an HFC diet; CMT: castrated male pigs fed an HFC diet and given testosterone replacement therapy.
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DEGs (P < 0.05; Figure 5B). The enriched pathways are
listed in Additional file 6. Moreover, pathway analysis
showed that these genes were mainly involved in meta-
bolic pathways, steroid hormone biosynthesis, the PPAR
signaling pathway, peroxisomes, fatty acid degradation,
pyruvate metabolism, steroid biosynthesis, the nuclear
factor-kappaB (NF-κB) signaling pathway, primary bile
acid biosynthesis, antigen processing and presentation,Figure 5 Gene ontology (GO) and pathway analysis of differentially e
processes) associated with the identified DEGs. The vertical axis represents
of the significant GO terms. (B) Top 20 significant pathways involving DEG
axis represents the -Log2(P-value) of the significant pathways. Greater -Logthe tricarboxylic acid cycle, synthesis and degradation of
ketone bodies, and glycerolipid metabolism (Figure 5B,
Additional file 6).
Series-cluster analysis of DEGs
To refine the set of genes that were differentially
expressed between any group, we categorized the 2595
DEGs into seven possible model profiles (Additional file 7)
to enrich for gene expression tendencies using the Shortxpressed genes (DEGs). (A) Top 20 significant GO terms (biological
the GO category, and the horizontal axis represents the -Log2(P-value)
s. The vertical axis represents the pathway category, and the horizontal
2(P-value) scores correlated with increased statistical significance.
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identified two patterns of gene expression (profiles 2 and
5, Additional file 8) with significance (P < 0.05; Figure 6A).
Profile 2 contained 738 genes that were characterized by
decreased expression in CM pigs but increased expression
in the CMT group. In contrast, profile 5 contained 869
genes that were characterized by increased expression in
CM pigs but exhibited decreased expression in the CMT
group. Significantly enriched GO terms from profiles 5
and 2 are illustrated in Figure 6B and Additional files 9
and 10. Cluster analysis showed that the significantly
enriched GO terms from profile 5 were closely correlated
with immune and inflammatory responses. The included
genes were enriched in the type I interferon signaling
pathway, cytokine-mediated signaling pathways, regula-
tion of immune responses, innate immune responses, im-
mune responses, and antigen processing and presentation
(Figure 6B, Additional file 9). Profile 5 genes were alsoFigure 6 Significant gene expression tendencies and gene ontology (
described in Additional file 3 (Table S4) were separated into seven possible
(profiles 2 and 5). Profile 2 included 737 genes that were decreased in CM
were increased in CM pigs, but decreased in CMT pigs. (B) Significantly enr
and the case genes in each cluster are listed. IM: intact male pigs fed an H
pigs fed an HFC diet and given testosterone replacement therapy.enriched in apoptotic processes and positive regulation of
chemokine secretion (Additional file 9).
The genes involved in immune and inflammatory res-
ponses are displayed and clustered in Figure 7A. To
verify the observed differential mRNA expression of im-
mune and inflammatory response genes, we performed
quantitative real-time RT-PCR (qRT-PCR) using RNA
samples extracted from the livers of IM, CM, and CMT
pigs. The hepatic expression of six immune and inflam-
matory response-related genes (IRF7, CXCL9, CXCL14,
CCL2, CCR1, and TLR-2) was analyzed in the three
groups. Consistent with RNA-Seq results, the expression
of these six genes was upregulated in CM pigs and
downregulated in CMT pigs after testosterone treatment
(Figure 7B). In addition to qRT-PCR validation experi-
ments, we also employed immunohistochemistry to exam-
ine the protein expression levels of CCL2, CXCL9, and
IRF7 (Figure 7C), which are involved in the developmentGO) analysis. (A) Differentially expressed genes between the groups
model profiles, including two significant gene expression tendencies
pigs, but increased in CMT pigs. Profile 5 included 838 genes that
iched GO terms in profiles 2 and 5. The top 15 biological functions
FC diet; CM: castrated male pigs fed an HFC diet; CMT: castrated male
Figure 7 Expression of genes involved in immune and inflammatory responses. (A) Heat map for genes involved in immune and
inflammatory responses. (B) Expression levels of six genes detected by quantitative real-time RT-PCR (yellow box) were in agreement with the
RNA-Seq results. Data are expressed as means ± SEMs, n = 6 per group. (C) Immunohistochemical assessment of chemokine (C-C motif) ligand 2
(CCL2), chemokine (C-X-C motif) ligand 9 (CXCL9), and interferon-regulatory factor 7 (IRF7), showing expression changes that were in accordance
with the RNA-Seq and qRT-PCR results. IM: intact male pigs fed an HFC diet; CM: castrated male pigs fed an HFC diet; CMT: castrated male pigs
fed an HFC diet and given testosterone replacement therapy. Scale bars = 100 μm.
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served similar differences in expression at the protein
level. Staining levels tended to be increased in the
livers of CM pigs compared to those observed in IM
pigs (Figure 7C). However, this positive staining was
reduced after testosterone treatment (Figure 7C).
Profile 2 genes were mainly enriched in various meta-
bolic subprocesses, including fatty acid metabolism, fatty
acid beta-oxidation, steroid biosynthesis, cholesterol and
bile acid metabolism, and glucose metabolism (Figure 6B,
Additional file 10). We found that the most genes
enriched in fatty acid metabolic processes were involved
in fatty acid oxidation (Figure 8A). It is well known that
impaired fatty acid oxidation contributes to NAFLD;
thus, we analyzed the genes participating in fatty acid
oxidation further. Carnitine palmitoyltransferase 1A
(CPT-1A) encodes the rate-limiting enzyme in fatty acid
oxidation, which was downregulated 2.36-fold in the
livers of CM pigs and upregulated 2.30-fold in the livers
of CMT pigs. Peroxisome proliferator-activated receptor
delta (PPARD) belongs to a class of ligand-dependent
transcription factors involved in hepatic lipid metabolismFigure 8 Expression of genes involved in fatty acid oxidation and cho
genes involved in fatty acid oxidation. (B) Heat map for genes involved in
in glucose metabolism. (D, E) Expression levels of six genes detected by qu
RNA-Seq results. Data are expressed as means ± SEMs, n = 6 per group. (F,
delta (PPARD) and carnitine palmitoyltransferase 1A (CPT-1A) showing expr
results. IM: intact male pigs fed an HFC diet; CM: castrated male pigs fed an
testosterone replacement therapy. Data are expressed as means ± SEMs, n =and was downregulated 2.18-fold in the livers of CM
pigs and upregulated 1.81-fold in the livers of CMT
pigs. Moreover, the ACADL, ACOX1, ACO, and ECIl
genes, encoding long-chain acyl-CoA dehydrogenase,
palmitoyl acyl-CoA oxidase 1, acyl-CoA oxidase, and
mitochondrial enoyl-CoA isomerase, respectively, were
2.66-, 2.05-, 1.99-, and 1.95-fold downregulated in the
livers of CM pigs and 4.00-, 1.65-, 1.51-, and 2.52-fold
upregulated in the livers of CMT pigs, respectively
(Figure 8).
Enriched genes mediating cholesterol, bile acid, and
glucose metabolism are also displayed in Figure 8. Genes
involved in cholesterol biosynthesis (PMVK and TM7SF2),
cholesterol esterification (LCAT and SORT2), cholesterol
transport and absorption (LDLR and LIPC), and bile acid
metabolic processes (NR1H4 and HSD3B7) were down-
regulated in the livers of CM pigs, but restored by testos-
terone treatment (Figure 8B). Several genes encoding
enzymes involved in glucose metabolism were also down-
regulated in CM pigs. For example, PCK1, encoding the
rate-limiting gluconeogenesis enzyme phosphoenolpyr-
uvate carboxykinase (PEPCK), and PFKFB1, encoding thelesterol, bile acid, and glucose metabolism. (A) Heat map for
cholesterol and bile acid metabolism. (C) Heat map for genes involved
antitative real-time RT-PCR (qRT-PCR) that were in agreement with the
G) Western blot analysis of peroxisome proliferator-activated receptor
ession changes that were in accordance with RNA-Seq and qRT-PCR
HFC diet; CMT: castrated male pigs fed an HFC diet and given
5 per group. *P < 0.05.
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creased in the livers of CM pigs, but increased in the livers
of CMT pigs after testosterone treatment (Figure 8C).
We performed qRT-PCR to verify the mRNA expression
profiles of the fatty acid oxidation-related genes CPT1A,
PPARD, ACADL, ACO, ACOX1, and 3-hydroxyacyl-CoA
dehydrogenase (HADH). Consistent with RNA-Seq ana-
lysis, the expression of these six genes was downregulated
in CM pigs and upregulated in CMT pigs after testoster-
one treatment (Figure 8D, E). We then measured the pro-
tein expression levels of CPT1A and PPARD by western
blot analysis. The protein levels of CPT1A and PPARD
were decreased in the livers of CM pigs as compared to
IM pigs and were increased in CMT pigs after testoster-
one treatment (Figure 8F, G).
Pathway-Act-Network analysis
To further understand the importance of pathway inter-
actions and to screen key pathways for significant roles
in NAFLD induced by testosterone deficiency and an
HFC diet, we built a Pathway-Act-Network according to
the direct or systemic interactions assigned between
pathways in the KEGG database (Figure 9, Additional
file 11). As shown in Figure 9, some DEGs involved in
key pathways during NAFLD were identified, includingFigure 9 Pathway-Act-Network analysis. The Pathway-Act-Network was
KEGG database. Cycle nodes represent pathways, and the arrow between t
of nodes represents the power of the interaction among the pathways (Ad
nodes represent nonsignificant pathways.metabolic pathways, fatty acid degradation, pyruvate me-
tabolism, and the citrate cycle. Moreover, glycerolipid
metabolism and the NF-κB signaling pathway in the
interaction network were also predicted to play import-
ant roles.
To display a detailed pathway of fatty acid degradation
and the relative differences in genes influenced by tes-
tosterone, a putative pathway of fatty acid degradation
was constructed based on KEGG mapping. Enzymes and
proteins involved in regulating fatty acid degradation
(CPT-1A, ACO, and ACADL) were decreased in CM
pigs, but recovered in CMT pigs (Additional file 12). We
also constructed a putative pathway of peroxisome-related
processes according to KEGG mapping (Additional file 13).
Similarly, several genes involved in regulating peroxisome
processes, such as PMP70 and PEX14, were decreased in
CM pigs, but increased in CMT pigs.
Discussion
In this work, we studied the effects of testosterone on
the development of hepatic steatosis in pigs fed an HFC
diet. Our data indicated that serum cholesterol (TC and
LDL-C, but not HDL-C) and TG levels were significantly
higher in CM pigs than in IM pigs. Moreover, testoster-
one deficiency exacerbated liver injury and increasedbuilt according to the interactions with pathways identified in the
wo nodes represents an interaction target between pathways. The size
ditional file 11). Red nodes represent significant pathways and green
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However, testosterone replacement attenuated these ef-
fects in CM pigs, suggesting that testosterone may play a
protective role in diet-induced hepatic steatosis. In pre-
vious studies, researchers have used rodent models to
evaluate the effects of testosterone on NAFLD; however,
several of these were genetic animal models, i.e., andro-
gen receptor (AR)-knockout mice [14] and Tfm mutant
mice [7]. These models may have some utility for specific
research aims, but most humans that develop NAFLD
have few genetic defects. Other studies have also used
orchidectomized mouse models; however, these animals
do not have increased adiposity [26] or have reduced
serum TG levels [6,26], which are inconsistent with find-
ings in humans. We showed here that a porcine model of
NAFLD induced by testosterone deficiency and HFC diet
mimicked human fatty liver disease in terms of histo-
logical analyses and metabolic profiles. To the best of our
knowledge, the present study is the first to demonstrate
that testosterone deficiency aggravates diet-induced hep-
atic steatosis in a porcine model. Testosterone deficiency
also caused significant changes in body fat percentages
and serum biochemical parameters. Previous studies have
shown that enzymes involved in fatty acid synthesis are in-
creased in adipose tissues of castrated male pigs [19].
Thus, the higher body fat content observed in CM pigs
may be due to the increased fatty acid synthesis in adipose
tissue [27]. Estradiol has been reported to decrease fatty
acid synthesis by increasing the phosphorylation of acetyl
coenzyme-A carboxylase in rats fed a high-fat diet [15].
Moreover, previous studies have reported that serum ALT
levels are significantly elevated in ovariectomized mice fed
an HFC diet [8], and estradiol administration reduces hep-
atic MDA content but increases SOD activity in rats with
hepatic fibrosis [28]. Thus, the significant changes in body
fat and serum parameters induced by castration may be
partly attributed to a reduction in estradiol [20]. However,
we did not measure hepatic estradiol levels, and elucida-
tion of the role of estrogens in the regulation of fat metab-
olism and serum parameters was not the primary goal of
our study; these will be investigated in future studies.
In this study, we found that testosterone deficiency did
not affect serum fasting glucose and insulin levels or
HOMA-IR in CM pigs compared to IM pigs. However,
testosterone replacement significantly reduced serum in-
sulin levels and HOMA-IR in CM pigs. While previous
studies have shown that androgen deficiency increases
fasting glucose levels and reduces insulin sensitivity (IR)
[29,30], the effects of testosterone on glucose metabol-
ism and IR in clinical observations and experimental
studies have not been consistent. For example, several
studies have shown that low serum testosterone levels
are associated with IR in men and that androgen therapy
improves IR and fasting glucose levels in men [31,32].However, other studies have found that reduction of tes-
tosterone levels in men did not significantly affect fast-
ing glucose levels or IR [33,34]. Moreover, castration
results in slightly increased fasting glucose levels, but
has no effects on fasting insulin concentrations and IR
in rats [35]. However, Nikoleanko et al. [26] showed that
fasting glucose, fasting insulin, and HOMA-IR levels
were not elevated in castrated male rats compared to in-
tact animals and animals receiving testosterone replace-
ment therapy. Using different mouse strains and diets,
Inoue et al. [36] also indicated that castration does not
induce serum glucose and insulin levels or related IR
markers in any of the mouse models studied. To date,
few reports have described the effects of testosterone on
glucose metabolism and IR in pigs. Our previous study
showed that there were no differences in serum levels of
glucose and insulin between intact and castrated male
pigs fed a normal diet [19]. In the present study, we still
found that testosterone deficiency did not change fasting
serum glucose and insulin levels in pigs fed an HFC diet.
Our results were not consistent with those obtained by
Christofferson et al. [20], who found that castration re-
sults in disturbed glucose metabolism. These discrepan-
cies may be explained by breed differences and the
different experimental model of testosterone deficiency.
Little is known regarding the molecular mechanisms
underlying the testosterone deficiency-mediated promo-
tion of fat deposition in the liver. Hepatic steatosis is
regulated by multiple metabolic pathways. Previous
studies have shown that disturbances in fatty acid oxida-
tion account for excess lipid storage in the liver [37,38].
We found that many genes involved in fatty acid oxida-
tion were downregulated in the livers of CM pigs, and
these effects were prevented by testosterone replace-
ment. PPARD regulates lipid oxidation processes [39,40],
but its role in hepatic lipid metabolism remains unclear.
We found that the levels of PPARD mRNA and protein
were significantly reduced in the livers of CM pigs, and
testosterone treatment restored the expression of PPARD
in CMT pigs. These results are consistent with those ob-
tained by Barroso et al. [41] and Bolic et al. [42], who
showed that PPARD activation stimulates hepatic fatty
acid oxidation and alleviates diet-induced hepatic steato-
sis. Moreover, this observation suggests that PPARD may
be regulated by sex hormones and plays key roles in the
regulation of hepatic steatosis; this provides a novel view
of PPARD function in the modulation of hepatic lipid me-
tabolism. In addition to its effects on lipid metabolism,
PPARD has been reported to play roles in the regulation
of glucose metabolism and IR [40,43]. Studies in genetic
and diet-induced IR or diabetic mice have shown that
PPARD exerts beneficial effects to ameliorate IR [40,43-45].
Because of our data regarding PPARD, and since the in-
volvement of PPARD in IR is well established, we would
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compared with those in IM and CMT pigs. However,
there was no difference in fasting glucose, insulin, or
HOMA-IR levels in CM pigs compared to IM pigs. Pre-
vious studies have indicated that PPARD regulates glu-
cose flux and IR through the pentose phosphate
pathway [40,43,46]. However, our transcriptomics data
did not reveal any changes in the expression levels of
glucose-6-phosphate dehydrogenase (G-6-PDH) and
phosphogluconate dehydrogenase (PGD) (two key en-
zymes in the pentose phosphate pathway) in the livers
of CM pigs compared to those of IM pigs. Moreover,
PPARD has been reported to reduce glucose production
indirectly via activation of AMPK rather than through a
direct mechanism [40,47]. In our study, expression
levels of AMPK and adiponectin signaling genes (ADI-
POQ, ADIPOR1, and ADIPOR2) were not changed in
CM pigs compared to IM pigs. Activation of PPARD has
failed to enhance severe IR [47-49]. Moreover, in recent
studies in rats and mice fed a high-fat diet, heteroge-
neous effects of PPARD on IR have been observed [49].
Thus, the reasons for the discrepancy between PPARD
expression and IR markers in this study may be due to
the different effects of PPARD on IR in different species
[49]. However, testosterone replacement significantly
improved fasting insulin and HOMA-IR levels and re-
stored PPARD expression in CM pigs, despite the obser-
vation that gonadectomy apparently did not change
fasting insulin, glucose, or HOMA-IR levels compared
to those in intact pigs. CPT-1A is the rate-limiting en-
zyme of mitochondrial β-oxidation [50]. We found that
hepatic CPT1A mRNA and protein levels were signifi-
cantly reduced in the livers of CM pigs and subse-
quently restored in CMT pigs receiving testosterone
supplementation. Other fatty acid oxidation-related
genes, such as ACADL, ACOX1, ACO, HADH, and short
chain enoyl-CoA hydratase (ECHS1) were also down-
regulated in the livers of CM pigs. Taken together, our
results provided strong evidence that testosterone defi-
ciency aggravated hepatic fat accumulation in CM pigs
partly due to decreased hepatic fatty acid oxidation. Our
results are consistent with a human study in which men
with short-term hypogonadism showed decreased
whole-body lipid oxidation [51]. Moreover, Lin et al.
[14] observed reduced fatty acid oxidation in isolated
primary hepatocytes from hepatic AR-knockout (H-AR-/y)
mice, consistent with our results. Peroxisomes have many
important functions in lipid metabolism, including fatty
acid β-oxidation. A previous study reported that impaired
peroxisome function contributes to NAFLD in mice [52].
In this study, we also found that the PMP70, PEX14, and
PEM34 genes, which are involved in peroxisome-related
processes, were downregulated in the livers of CM pigs.
These results suggested that testosterone deficiency led toincreased hepatic steatosis in CM pigs by affecting peroxi-
some function.
In addition to the decrease in liver fat oxidation, in-
creased fat synthesis may also contribute to elevated liver
fat accumulation [53]. TGs are the main lipids that accu-
mulate during hepatic steatosis [54]. Glycerol 3-phosphate
acyltransferase (GPAT) and diacylglycerol acyltransferase
(DGAT) catalyze the initial and final steps in TG synthe-
sis, respectively [55,56]. Increased levels of DGAT1 mRNA
occur in the livers of humans with NAFLD [57], indicating
the importance of DGAT1 in fatty liver development.
Mice lacking DGAT1 have reduced tissue TG levels and
are protected against hepatic steatosis [56]. Studies using
GPAT-knockout mice [58] and mice overexpressing GPAT
in the liver [55] have implicated this enzyme in hepatic
steatosis. Stearoyl-CoA desaturase (SCD) catalyzes the de
novo biosynthesis of monounsaturated fatty acids (mainly
oleate and palmitoleate), which are critical substrates for
the synthesis of TGs by GPAT [59]. To date, few studies
have been conducted to explore the effects of testosterone
on hepatic TG synthesis enzymes. Senmaru et al. [6] re-
ported that orchidectomized mice fed HFD showed sig-
nificantly increased DGAT2 expression. A recent study
revealed that SCD1 expression was significantly elevated
in Tfm mice than in wild-type controls [7]. These observa-
tions are consistent with our findings that the expression
of the TG synthesis genes GPAT, DAGT, and SCD were
significantly upregulated in the livers of CM pigs and that
testosterone replacement reduced their expression in CM
pigs. Our results suggested that testosterone deficiency
might increase liver fat accumulation by inducing hepatic
TG synthesis. Acetyl-CoA carboxylase alpha (ACACA)
and fatty acid synthase (FASN) are also key lipogenic en-
zymes involved in hepatic lipid deposition. A recent study
showed that hepatic ACACA and FASN expression levels
were elevated in Tfm mice compared with wide-type lit-
termates [7]. However, Nikolaenko et al. [26] found that
there were no significant differences in liver FASN protein
levels in C +HFD mice after castration. These results are
inconsistent with our findings, which showed decreased
ACACA and FASN expression in the livers of CM pigs.
These differences might be species-specific or result from
different experimental models of hepatic steatosis. In
addition, hepatic fatty acid synthesis requires acetyl-CoA
generated from multiple metabolic pathways, including
glycolysis, the tricarboxylic acid cycle, and fatty acid β-
oxidation [60]. Thus, the observed decrease in ACACA
and FASN expression may be due to impaired glucose me-
tabolism or fatty acid oxidation in the present study.
The spectrum of NAFLD ranges from simple fatty
liver (hepatic steatosis) to nonalcoholic steatohepatitis
(NASH; steatosis with inflammation and fibrosis). The
“two-hit” theory of NAFLD progression proposes that
inflammation, oxidative stress, and apoptosis play critical
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Gene expression profiling indicated that several immune
and inflammatory response genes were activated in the
livers of CM pigs. Chemokines direct the trafficking of
immune cells to sites of inflammation [62]. Chemokine
(C-C motif) ligand 2 (CCL2; commonly known as mono-
cyte chemoattractant protein-1 [MCP-1]) is one of the
most important chemokines involved in inflammation,
and elevated levels of CCL2 have been confirmed in the
livers of patients with NAFLD [63,64]. Moreover, in-
creased hepatic and serum MCP-1 expression levels have
been described in diet-induced NAFLD [62,65]. Expres-
sion levels of C-C chemokine receptor 1 (CCR1) and che-
mokine (C-X-C motif) ligands 9, 10, 14 (CXCL9, CXCL10,
and CXCL14) are increased in livers during HFD-induced
hepatic steatosis [65-67]. We found that testosterone defi-
ciency significantly increased mRNA and protein levels of
the CCL2, CXCL9, CCR1, CXCL10, and CXCL14 chemo-
kines in the livers of CM pigs, and testosterone replace-
ment abolished these effects. Our data suggested that the
induction of pro-inflammatory chemokines contributes to
the mechanism of inflammatory recruitment in hepatic
steatosis induced by testosterone deficiency and an HFC
diet. Moreover, clinical and experimental observations
have shown that tumor necrosis factor (TNF) may have a
pathogenic role during NAFLD development, specifically
by modulating chronic lobular inflammation with hepato-
cellular injury [63,67]. We found that hepatic TNF expres-
sion was reduced in CM pigs. This is inconsistent with
previous observations [63,68]. Dela Pena et al. [69] dem-
onstrated that knocking out the TNF gene does not pre-
vent diet-induced NAFLD in mice. Similar studies by
Deng et al. [70] showed that TNFR1-knockout mice still
develop hepatic steatosis. Taken together, these studies
suggest that TNF may not be a critical mediator of inflam-
mation in this experimental form of hepatic steatosis. In
the present study, numerous immunity and inflammation-
related processes, including antigen processing and
presentation, cytokine-mediated signaling pathways, and
chronic inflammatory responses were induced in the livers
of CM pigs. Interestingly, previous studies have shown
marked induction of numerous immunity- and
inflammation-related pathways in PPARD−/− mice
[46]. Moreover, activation of PPARD may improve hep-
atic steatosis via directly suppressing the expression of
cytokines or transcription factors associated with in-
flammation [71,72]. These observations suggest that
testosterone deficiency may induce immune and in-
flammatory responses through modulation of hepatic
PPARD expression. Moreover, testosterone has been
suggested to act directly on immune cells by repressing
transcription factors (such as FOS, JUN, and others)
[73,74]. In our study, CM pigs had higher FOS expres-
sion than IM pigs. Moreover, testosterone replacementsignificantly reduced the increased FOS expression in
CMT pigs. These results suggested that testosterone
may inhibit liver FOS expression in CM pigs, thereby
regulating the expression of genes involved in the im-
mune response [74]. Additionally, previous studies
have shown that testosterone can bind to intracellular
receptors located in immune cells and activate hormone-
responsive genes [74,75]. In our study, androgen receptor
expression was reduced by about 1.8 fold in the livers of
CM pigs compared to those in IM and CMT pigs, suggest-
ing that testosterone may interact with immune cells
through its receptor. Therefore, further studies are needed
to elucidate the precise mechanisms mediating the ob-
served responses.
Oxidative stress plays critical roles during the develop-
ment of NAFLD [9]. SOD1 is an important antioxidant
enzyme that can reduce reactive oxygen species and pro-
tect hepatocytes. SOD1 deficiency caused high levels of
oxidative stress in the liver, resulting in hepatic lipid ac-
cumulation in mice [76]. In the present study, hepatic
SOD1 gene expression was significantly decreased in the
livers of CM pigs compared to IM pigs, suggestive of a
reduced defense mechanism against oxidative stress. In
contrast to SOD1, cytochrome P450 2E1 (CYP2E1) ex-
erts pro-oxidant activity and may enhance oxidative
stress. CYP2E1 expression in the liver is increased in
humans and animal models of NAFLD [77]. Moreover,
CYP2E1-null mice are protected against HFD-induced
obesity and hepatic steatosis [78]. We showed that tes-
tosterone deficiency significantly induced hepatic expres-
sion of CYP2E1 and that testosterone replacement
abolished these effects. Our data are in accordance with
a previous study showing higher levels of CYP enzymes
(including CYP2E1) in hepatic tissues of castrated
ethanol-fed micropigs than in noncastrated counterparts
[79]. Increased oxidative stress may induce hepatocyte
apoptosis, resulting in more severe liver injury [80]. Al-
though hepatic apoptosis was not detected histologically,
it is important to note that several genes associated with
apoptosis, including B-cell leukemia/lymphoma-2 (BCL2),
caspase-2 (CASP2), and bcl-2 associated-x (BAX), were
upregulated in the livers of CM+HFC pigs in response to
testosterone deficiency in the present study. Similar to our
study, Nikolaenko et al. [26] demonstrated that testoster-
one treatment improved diet-induced hepatic apoptosis in
mice fed a high-fat diet.
The limitations of the current study include the small
number of animals studied and the lack of confirmation
of the results using human samples. Despite the fact that
pigs have served as a suitable animal model for studying
NAFLD, few animal models can entirely reflect the
natural course and causative background of human
NAFLD. Thus, it would be best to validate the identified
DEGs in patients with hepatic steatosis. Furthermore,
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high serum TG levels, although pigs developed severe
hypercholesterolemia and hepatic steatosis. The amount
and type of dietary fat and diet duration may have influ-
enced these effects. These issues should be addressed in
future studies.
Conclusions
In summary, we demonstrated here that testosterone de-
ficiency may aggravate hepatic steatosis and hyperchol-
esterolemia in pigs fed an HFC diet, and these effects
were improved by testosterone treatment. Importantly,
hepatic transcriptomic analysis revealed that increased
hepatic steatosis induced by testosterone deficiency and
an HFC diet was mediated by altered expression of
genes involved in multiple metabolic processes. We ob-
served abnormal regulation of fatty acid metabolism and
found that the expression of fatty acid oxidation-related
genes was reduced in the livers of CM pigs. Moreover,
genes associated with immune and inflammatory re-
sponses, oxidative stress, and apoptosis also contributed
to the increased hepatic steatosis. These observations
provide a molecular basis for understanding the mecha-
nisms through which testosterone deficiency aggravates
the progression of diet-induced hepatic steatosis.
Methods
Experimental animals
Eighteen sexually mature male Chinese Wuzhishan (WZS)
miniature pigs (6–7 months old) were obtained from the
Institute of Animal Sciences, Hainan Academy of Agricul-
tural Sciences (Haikou, China). The animals were housed
in single pens with a 12-h light/dark cycle. The room
temperature was maintained at 22 ± 3°C, with a relative
air humidity of 50% ± 20%. Before and after their arrival,
the animals were fed a standard swine diet and had free
access to water. The animals received a standard diet
without cholesterol during a 7-week “pretreatment period”
for acclimation to the environment and baseline determi-
nations. At week 7, the pigs were either surgical castrated
or given a sham operation as described previously [81].
Testosterone was administrated weekly to castrated pigs
via intramuscular injection with testosterone propionate
(10 mg/kg body weight; Sigma-Aldrich, St. Louis, MO,
USA) dissolved in corn oil [82]. Testosterone replacement
therapy was given on the same day of castration to avoid
disruption of hormonal influences. The pigs were fed an
HFC diet starting from week 8 and were divided into three
groups (n = 6 animals/group) as follows: intact male pigs
fed an HFC diet (IM), castrated male pigs fed an HFC diet
(CM), and castrated pigs with testosterone replacement
fed an HFC diet (CMT). The HFC diet was comprised of
73% normal swine diet, 15% lard, 10% egg yolk power,
1.5% cholesterol, and 0.5% sodium cholate. The HFC dietwas similar to an atherogenic diet, which has been shown
to induce hepatic steatosis and atherosclerosis [38,83].
Body weights were recorded every week for 12 weeks. All
experimental procedures used in this study were approved
by the Institutional Animal Care and Use Committee of
the Zhejiang Chinese Medical University (Hangzhou,
China).
At the end of the experimental period, the animals
were killed by exsanguination under sodium pentobarbital
anesthesia. The carcasses were eviscerated according to
the procedures as previously described [19], and the
carcass fat from the left side of each animal was
weighed. Livers were removed and weighed, and liver
weight indexes were calculated as the liver weight/body
weight ratio (g/kg). Livers were then frozen immediately
in liquid nitrogen and stored at −80°C for further analysis.
Serum measurements
Fasting blood samples were collected prior to castration
and twice weekly throughout the study. Sera were sepa-
rated from collected blood samples by centrifugation at
3000 × g at 4°C for 15 min and stored at −80°C for further
analysis. Serum testosterone and Insulin concentrations
were measured at week 7 (0 w; the start of the experi-
mental period after the 7-week acclimation) and week
19 (12 w; the end of the experimental period), using a
commercial RIA kit (Beijing North Institute of Bio-
logical Technology, Beijing, China). Serum TGs, TC,
HDL-C, LDL-C, glucose, ALT, and AST were measured
with an Automatic Biochemistry Analyzer (Hitachi
7020, Tokyo, Japan). HOMA-IR was calculated using
the formula, base glucose × base insulin/22.5 [8,26].
Serum FFAs, SOD, glutathione peroxidase (GSH-PX),
and MDA were measured using commercially available
kits (Nanjing Jiancheng Biotech, Inc., Nanjing, China).
Biochemical analysis in liver samples
Hepatic lipids were measured using the methods de-
scribed by Shi et al. [84] with slight modifications.
Briefly, liver samples from each pig were homogenized
at 4°C in phosphate-buffered saline (PBS, pH 7.2). Su-
pernatants were then centrifuged at 3000 × g for 10 min
at 4°C, and TG and TC levels were determined using
commercially available kits (Rongsheng Biotech, Inc.,
Shanghai, China) according to the manufacturer’s in-
structions. Protein concentrations in the liver samples
were measured with a BCA Assay Kit (Pierce, Rockford,
IL, USA).
Liver histology
For histopathological analysis, pig liver tissues were fixed
in 10% formalin, embedded in paraffin, and sectioned at
5-μm thicknesses using a microtome (Leica, Wetzlar,
Germany). Subsequently, sections were stained with
Cai et al. BMC Genomics  (2015) 16:59 Page 15 of 19hematoxylin and eosin (H&E). In addition, frozen liver
samples were embedded in Tissue-Tek OCT Com-
pound (Sakura Finetek, Torrance, CA, USA), sectioned
at 10-μm thicknesses using a cryostat (Leica), and
stained with Oil Red O (Sigma-Aldrich) to study fat de-
position. For each of the indicated histological proce-
dures, representative photomicrographs were taken
with a light microscope (Nikon Eclipse 80i, Nikon,
Tokyo, Japan).
cDNA library preparation and Illumina sequencing
Liver tissues from pigs were subjected to total RNA ex-
traction using TRIzol reagent (Invitrogen, Carlsbad, CA,
USA) according to the manufacturer’s instructions. RNA
samples were purified using an RNeasy Mini Kit (Qiagen,
Hilden, Germany). RNA integrities were assessed with a
2100 Bioanalyzer (Agilent Technologies, Inc., Santa Clara,
CA, USA) and agarose gel electrophoresis. All samples
had a RNA integrity number (RIN) of more than 8.5. To
reduce variation among individuals within each of the
three groups, total RNA from pigs of the same group was
pooled together in equal amounts to generate a mixed
sample [85,86]. These three pooled RNA samples were
subsequently used for cDNA library construction and Illu-
mina deep sequencing. Sequencing libraries were prepared
using a TruSeq RNA Sample Preparation Kit (Illumina,
San Diego, CA, USA) according to the manufacturer’s in-
structions. Briefly, 10 μg of each total RNA sample was
processed via poly-A selection with oligo(dT) magnetic
beads and fragmentation. The resulting fragmented
mRNAs were then processed by first-strand cDNA syn-
thesis using reverse transcription with random primers,
followed by second-strand cDNA synthesis using DNA
polymerase I and RNase H (Invitrogen). Paired-end (PE)
oligo adapters (Illumina) were then added to the cDNA
fragments with T4 ligase. The resulting cDNA fragments
were purified and enriched by polymerase chain reaction
(PCR). The cDNA libraries were sequenced with an Illu-
mina HiSeq2000 (Illumina), which generated paired-end
raw reads of approximately 100-bp in size.
Raw sequencing data were evaluated by FAST-QC
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc),
an online bioinformatics program used to characterize
quality distributions of nucleotides, position-specific se-
quencing qualities, GC contents, the proportions of PCR
duplication, and k-mer frequencies [87]. Raw reads after
quality control testing were then mapped to the reference
pig genome version 10.2 (Sscrofa 10.2), using TopHat soft-
ware [88] with default parameters.
Analysis of DEGs
We applied the DEGSeq [22] algorithm to filter DEGs.
The resulting significance scores were corrected for mul-
tiple testing using the Benjamini-Hochberg (BH) method[23]. An FDR of 0.05 or less and an absolute fold change
of 1.5 or more were set as thresholds to evaluate the sig-
nificance of gene expression differences [24]. The cluster-
ing software Cluster 3.0 was used to perform hierarchical
clustering analysis. Clustering results were visualized using
the Java TreeView program [89].Functional enrichment analysis
To investigate gene functions and uncover signaling net-
works/pathways among the selected DEGs, GO analysis
was applied to analyze the main function of DEGs ac-
cording to the NCBI Gene Ontology database, which
provides key functional classifications for genes [90]. Ac-
cording to the methods described by Wang et al. [91],
Fisher’s exact test and the χ2 test were used to classify
the GO terms, and the FDR was calculated to correct
the P-value. The smaller the FDR, the smaller the error
would be when evaluating the P-value. The FDR was de-
fined as DR ¼ 1− NkT , where Nk refers to the number of
Fisher’s test P-values less than the χ2 test P-values. En-
richment provided a measure of the significance of the
function, such that as the enrichment was increased, the
corresponding function was more specific, which aided
in experimentally identifying GOs with more concrete
functions [91]. GO categories with P-values of less than
0.01 after correction by FDR were selected for further
analysis.
Pathway analysis was used to determine significant
pathways associated with DEGs according to KEGG
(http://www.genome.jp/kegg). As with the GO analysis,
Fisher’s exact test was used to classify significantly
enriched pathways, and the resulting P-values were ad-
justed using the FDR algorithm. During the analysis of
KEGG pathway terms, we required corrected P-values to
be less than 0.05. In addition, the enriched pathways
were selected to build Pathway-Act-Networks according
to the relationships identified between the pathways in
the KEGG database. Pathway assignments were also
performed using the KEGG database and KegArray
software [92].
The expression profiles of DEGs were determined by
cluster analysis based on the STEM method (http://www.
cs.cmu.edu/~jernst/st/) [25,93]. Significant profiles were
identified using Fisher’s exact test and multiple compari-
sons. GO analysis was also applied to the genes belonging
to specific profiles.qRT-PCR analyses
Total RNA from liver specimens was isolated using TRI-
zol reagent (Invitrogen) according to the manufacturer’s
instructions. Approximately 1 μg total RNA was used
for first-strand cDNA synthesis, which was carried out
using an MMLV-RT Kit (Promega, Madison, WI, USA)
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performed using the StepOnePlus Real-Time PCR De-
tection System (Applied Biosystems, Inc., Foster City,
CA, USA). The primers used for measuring the expres-
sion of mRNAs of interest are listed in Additional file
14. The amplifications were performed in 20-μL reaction
mixtures containing 10.4 μL of 2× SYBR Premix Ex
Taq (TaKaRa, Dalian, China), 0.4 μL of each primer
(10 mM), 7.8 μL distilled water, and 1.0 μL cDNA. The
following PCR conditions were used for all genes: 95°C
for 5 min, followed by 40 cycles of 95°C for 15 s, 60°C
for 30 s, and 72°C for 30 s. After amplification, melt
curve analysis was performed to confirm the specificity
of the reaction. All measurements were performed in
triplicate. β-Actin was used as a reference gene to
normalize gene expression. The 2-ΔΔCT method was used
to analyze the qRT-PCR data and assign relative expres-
sion differences [94].
Immunohistochemistry analysis
Immunohistochemistry was performed with paraffin-
embedded sections using standard protocols. Briefly,
liver sections were deparaffinized in xylene and rehy-
drated through a graded ethanol series. Endogenous per-
oxidase was blocked with 3% hydrogen peroxide (H2O2).
The sections were boiled in 10 mM citrate buffer
(pH 6.0) for 15 min for antigen retrieval. After blocking
with 5% normal goat serum, sections were incubated at
4°C overnight with the following primary antibodies:
anti-CCL2 (1:100; ab7814, Abcam, Cambridge, MA,
USA), anti-CXCL9 (1:50; bs-2551R, Bioss, Beijing, China),
and anti-IRF7 (1:250; bs-2994R, Bioss). Thereafter, the
sections were rinsed in PBS and incubated with a biotinyl-
ated secondary antibody. The antigen was visualized with
a diaminobenzidine (DAB) kit (Vector Laboratories, Bur-
lingame, CA, USA) and counterstained with hematoxylin.
A negative control without the primary antibody was
included. Images were acquired using a Nikon Eclipse
80i fluorescence microscope and a DS-Fil CCD camera
(Nikon).
Western blot analysis
Total protein was extracted from frozen liver samples
(~80 mg) as described previously [2]. Samples were cen-
trifuged for 15 min at 4°C and 12,000 × g, and superna-
tants were collected. Protein concentrations were
measured with a BCA Protein Assay Kit (Pierce). After
denaturation, liver protein samples were resolved by 10%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
and transferred to polyvinylidene membranes (Millipore
Corp., Billerica, MA, USA). Membranes were stained with
Ponceau S to visually check the quality of proteins that
were transferred and were then blocked for 1 h in 1× TBS
with 5% nonfat milk. Primary antibodies against CPT1A(1:400; SAB2100476, Sigma-Aldrich), PPARD (1:600;
AV32878, Sigma-Aldrich), and GAPDH (1:600; SC-16654,
Santa Cruz Biotechnology, Santa Cruz, CA, USA) were
incubated with the membrane over night at 4°C. Mem-
branes were then washed and incubated with Odyssey
Infrared-labeled secondary antibodies (LI-COR Biosci-
ences, Lincoln, NE, USA) for 1 h in the dark at 37°C.
After the last washing step, the membranes were
scanned and analyzed using an Odyssey Infrared Imaging
System (LI-COR Biosciences).
Statistical analysis
Statistical analysis was performed using SPSS 13.0 soft-
ware (SPSS, Chicago, IL, USA). The results are presented
as means ± SEMs. Statistical differences between groups
were examined using the unpaired Student’s t- test. Differ-
ences with P-values of less than 0.05 were considered sta-
tistically significant.
Data accessibility
The sequence data from this study have been submitted
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(http://www.ncbi.nlm.nih.gov/geo) under accession number
GSE65696.
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differentially expressed genes (DEGs) between any groups of pigs
by model profiles. Figure showing the expression patterns of 2595
genes were summarized by 7 model profiles. Each box represents a
model profile. The upper number in the profile box is the model profile
number and the p-value is shown. Two expression patterns of genes had
significant p-values (p <0.05) (green and red colored boxes).
Additional file 8: The genes involving significant profiles. Table lists
the differentially expressed genes (DEGs) assigned in each significant
expression profile.
Additional file 9: Significant enriched GO terms and contributing
genes in profile 5.
Additional file 10: Significant enriched GO terms and contributing
genes in profile 2.
Additional file 11: The pathways used for pathway-net analysis.
Table S1. The pathways list of pathway-net analysis; Table S2. The
power of the interaction among pathways.
Cai et al. BMC Genomics  (2015) 16:59 Page 17 of 19Additional file 12: Differences in hepatic gene expression in the
KEGG fatty acid degradation pathway. (A) The CM group compared to
the IM group. (B) The CMT group compared to the CM group. The
colored small boxes correspond with genes detected in this study. Green:
downregulated expression; red: upregulated expression; gray: unchanged
expression. The numbers within the small boxes are enzyme codes. IM:
intact male pigs fed an HFC diet; CM: castrated male pigs fed an HFC
diet; CMT: castrated male pigs fed an HFC diet and given testosterone
replacement therapy.
Additional file 13: Differences in hepatic gene expression in the
KEGG peroxisome pathway. (A) The CM group compared to the IM
group. (B) The CMT group compared to the CM group. The colored small
boxes correspond with genes detected in this study. Green: downregulated
expression; red: upregulated expression; gray: unchanged expression. IM:
intact male pigs fed an HFC diet; CM: castrated male pigs fed an HFC diet;
CMT: castrated male pigs fed an HFC diet and given testosterone
replacement therapy.
Additional file 14: Information on primers used for quantitative
real-time RT-PCR.
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